Patents
Literature
Eureka-AI is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Eureka AI

20838 results about "Enzyme" patented technology

Enzymes /ˈɛnzaɪmz/ are macromolecular biological catalysts that accelerate chemical reactions. The molecules upon which enzymes may act are called substrates, and the enzyme converts the substrates into different molecules known as products. Almost all metabolic processes in the cell need enzyme catalysis in order to occur at rates fast enough to sustain life. Metabolic pathways depend upon enzymes to catalyze individual steps. The study of enzymes is called enzymology and a new field of pseudoenzyme analysis has recently grown up, recognising that during evolution, some enzymes have lost the ability to carry out biological catalysis, which is often reflected in their amino acid sequences and unusual 'pseudocatalytic' properties.

Tissue-specific and pathogen-specific toxic agents and ribozymes

InactiveUS6271359B1Rapidly and effectively expressedVirusesSugar derivativesCancer cellBiology
The present invention relates to the discovery, identification and characterization of toxic agents which are lethal to pathogens and methods for targeting such toxic agents to a pathogen or pathogen infected cells in order to treat and/or eradicate the infection. In particular, the present invention relates to toxic agents which target bacteria at different stages of the bacterial life cycle, which are delivered alone or in combination to bacteria or bacteria-infected cells. The invention relates to toxic agents which are lethal to diseased cells and methods for targeting such toxic agents to a diseased cell in order to treat and/or eradicate the disease. The present invention relates to promoter elements which are pathogen-specific or tissue-specific and the use of such promoter elements to achieve pathogen-specific or tissue-specific expression of the toxic agent(s) and/or ribozyme(s) of the present invention. Specifically, the invention relates to the delivery of one or more toxic gene products, antisense RNAs, or ribozymes, or combination thereof. The invention provides a novel system by which multiple pathogenic targets may be simultaneously targeted to cause the death of a pathogen, or cell infected with a pathogen. Further, the invention has important implications in the eradication of drug-resistant bacterium and bacterial pathogens. The invention provides a novel system by which multiple targets may be simultaneously targeted to cause the death of a diseased cell. The invention also has important implications in the eradication of drug-resistant pathogens and drug-resistant diseased cells (such as cancer cells).
Owner:MUSC FOUND FOR RES DEV +1

Packaging container for discharge of plurality of contents, packaging product including the packaging container and process for producing the packaging product

Double aerosol container (190a) comprising outer vessel (11), flexible inside bag (12) accommodated in the outer vessel and valve (13). The inside bag (12) is divided by means of middle constricted part (71) into upper and lower storage parts (27, 26), and the upper and lower storage parts are shut off from each other by means of partition member (72) at the constricted part. The valve (13) is fitted with a communication hole for communicating the upper storage part (27) with the inside of the inside bag (12) and flitted with dip tube (28) communicating with the lower storage part (26). The upper and lower storage parts (27, 26) are loaded with first contents (A) and second contents (B), which are different from each other, thereby providing an inside bag type double aerosol product. Two-pack type reactive preparations can be employed as a combination of contents of the double aerosol product The double aerosol product is suitable for use in, for example, a hair dye, an enzyme hair dye, a hair setting agent, an antiphlogistic analgesic, a glow inhibitor, a coolant, a pack agent, a cleansing agent, a shaving foam, a humectant, an antiperspirant, a vitamin or a skin softener.
Owner:DAIZO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products